Dr. Edward Christopher Borrazzo, MD

Dr. Borrazzo practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Borrazzo's NPI, 1215962501, was assigned on July 12, 2006. Dr. Borrazzo graduated from Renaissance School of Medicine at Stony Brook University in 1994. Dr. Borrazzo holds Vermont license 042-0010307.

Dr. Borrazzo's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Borrazzo's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Borrazzo is also affiliated with Champlain Valley Physicians Hospital. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Borrazzo to 2 more hospitals, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Borrazzo practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Borrazzo's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Borrazzo is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Borrazzo's licenses on file in 3 states: Vermont, New York and Pennsylvania.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, appendectomy, esophagus, stomach, or upper small intestine surgery, gallbladder removal and groin hernia surgery among the conditions Dr. Borrazzo treats.

CMS data shows 189 Medicare services from Dr. Borrazzo across 4 procedure codes in 2024, for 189 Medicare patients. Medicare paid $44,523 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 189 Medicare patients who saw Dr. Borrazzo in 2024. The largest group is 65 to 74, with 84 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Borrazzo's median patient age at 70, with 60% women.

In 2024, Dr. Borrazzo wrote 83 Medicare Part D claims for 35 patients. 99% of them were for generic drugs. CMS names the drug for 45 of them, across 2 drugs with 11 or more claims each, at $247 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

Dr. Borrazzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Borrazzo as offering telehealth. CMS counts 40 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Borrazzo, more than 60% of the clinicians it reports for that procedure.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Borrazzo, published from 2003 to 2023. 2003 was the busiest year, with 2. The most frequent topics are Laparoscopy and Intestines. Dr. Borrazzo has published most often in Surg Endosc. Dr. Borrazzo's most frequent co-authors are Sonam Ghanshyam Kapadia, MD, Steven Ades, MD and Christopher James Anker, MD.

CMS Open Payments shows 5 general payments to Dr. Borrazzo from 2 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 95% of the total. Medtronic, Inc. paid the most, $757.

Dmand AI lists 2 awards for Dr. Borrazzo, most recently CMS Stage 1 EHR in 2013.

Dr. Borrazzo graduated from Renaissance School of Medicine at Stony Brook University in 1994. Dr. Borrazzo is a member of ACS.

Dr. Borrazzo is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and MVP Health Care. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.